Ephrin-B2 antibody
Ref. 3D-20R-2035
| 50µg | 484.00 € |
Product Information
The Ephrin-B2 antibody is a monoclonal antibody that specifically targets Ephrin-B2, a protein involved in cell signaling and adhesion. This antibody has been extensively studied for its potential therapeutic applications in various diseases, including cancer.
Studies have shown that the Ephrin-B2 antibody can effectively inhibit the growth and spread of cancer cells by disrupting their interaction with surrounding tissues. It has been shown to block the binding of Ephrin-B2 to its receptor, leading to a decrease in cell proliferation and an increase in apoptosis (programmed cell death).
Furthermore, this antibody has demonstrated cytotoxic effects on cancer cells, making it a promising candidate for targeted therapy. It has also been investigated in combination with other anticancer agents, such as trastuzumab, to enhance their efficacy.
In addition to its anticancer properties, the Ephrin-B2 antibody has been found to play a role in other biological processes. It has been shown to regulate collagen synthesis, modulate epider
Chemical properties
Technical inquiry about: 3D-20R-2035 Ephrin-B2 antibody
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
